Delivering mitochondrial health
Abliva will attend the virtual BioStock Investor Meeting on March 16, 2023. CEO Ellen Donnelly will be presenting the company in BioStock's studio in Lund. The event will be broadcasted online on the BioStock website and YouTube channel.
We will digitally attend this year's BIO-Europe spring, hosted in Basel, Switzerland, on March 20 - 22, 2023. This major life science and biotech meeting offers a great opportunity for networking and partnering.
In April, we will attend this year's Kempen Life Science Conference in Amsterdam, Netherlands.
In mid-May, Abliva will attend and present at Bio€quity Europe 2023 in Dublin, Ireland. "For more than 20 years, Bio€quity Europe has been where CEOs and investors gather to network, partner and debate critical issues facing the biotech industry today." CEO Ellen Donnelly will present the company on May 15 during the session Other Approaches […]
On May 25, Abliva will participate at Erik Penser Bank's Penser Market Bolagsdag in Stockholm. Abliva's CMO, Magnus Hansson, will be presenting the company during the morning session. Further details and link to event below.
In late May, Abliva will attend and present at ABG Sundal Collier's Life Science Summit Seminar in Stockholm, Sweden. The event will also be live-streamed. See below for more info.
In early June, Abliva will attend the BIO International Convention in Boston, US.
In June, Abliva will attend this year's edition of Euromit - the international conference on mitochondrial disease. The meeting takes place in Bologna, Italy, and gathers researchers, clinicians, and patients for the sharing of knowledge and insights in the field. The conference also presents opportunities to meet with investigators in our FALCON study with KL1333.
In late June, Abliva will be attending this year's international Mitochondrial Medicine Symposium, organized by US patient organization United Mitochondrial Disease Foundation. The meeting will take place in Charlotte, North Carolina (US), on June 28 - July 1, and includes both scientific as well as patient and family sessions.
Abliva will participate at the 12th annual edition of 'The Future of Swedish & Danish Life Science', on September 7, 2023, in Lund, Sweden. The company's Chief Medical Officer, Magnus Hansson, will give a talk entitled Pivotal study design in a rare disease with no regulatory precedent – utilizing patient advocacy groups and registries. "The […]
In September, Abliva will attend the LSX World Congress USA, in Boston, MA. The event gathers North America’s leading Biotech, Medtech and Healthtech CEOs along with investors, big pharma, and advisors.
Our Chief Medical Officer, Magus Hansson, will give a talk at Penser South Company Day in Malmö, on September 14, 2023. Click the link below for more details and registration.
